Details of Disease

General Information of Disease (ID: DISV2EVE)

Disease Name Ocular cancer
Synonyms
neoplasm of eye proper; ocular tumour; ocular tumor; neoplasm of eye; eye neoplasm; malignant tumour of the eye; malignant tumour of eye; malignant tumor of the eye; malignant tumor of eye; malignant ocular tumour; malignant ocular tumor; malignant ocular neoplasm; malignant neoplasm of the eye; malignant neoplasm of eyeball of camera-type eye; malignant neoplasm of eye; malignant eyeball of camera-type eye neoplasm; malignant eye tumour; malignant eye tumor; malignant eye neoplasm; eyeball of camera-type eye cancer; eye neoplasm, malignant; eye cancer; cancer of the eye; cancer of eyeball of camera-type eye; cancer of eye
Disease Class 2D00-2D07: Ocular cancer
Definition A benign or malignant neoplasm affecting the structures of the eye.|Editor note: check to see whether structure is eye or eye + adnexa
Disease Hierarchy
DISWYHOH: Sensory system cancer
DISAT1Z9: Advanced cancer
DISBPSQZ: Head and neck cancer
DISMX03T: Eye neoplasm
DISV2EVE: Ocular cancer
ICD Code
ICD-11
ICD-11: 2D00-2D07
Expand ICD-11
'2D0Z
Expand ICD-10
'C69-C72; 'C69; 'C69.8; 'C69.9
Disease Identifiers
MONDO ID
MONDO_0002236
MESH ID
D005134
UMLS CUI
C0496836
MedGen ID
105418
SNOMED CT ID
363461003

Drug-Interaction Atlas (DIA) of This Disease

Drug-Interaction Atlas (DIA)
This Disease is Treated as An Indication in 1 Clinical Trial Drug(s)
Drug Name Drug ID Highest Status Drug Type REF
APX-3330 DMXIMQT Phase 1 NA [1]
------------------------------------------------------------------------------------

Molecular Interaction Atlas (MIA) of This Disease

Molecular Interaction Atlas (MIA)
This Disease Is Related to 1 DTT Molecule(s)
Gene Name DTT ID Evidence Level Mode of Inheritance REF
PRSS1 TT2WR1T Strong Biomarker [2]
------------------------------------------------------------------------------------
This Disease Is Related to 1 DOT Molecule(s)
Gene Name DOT ID Evidence Level Mode of Inheritance REF
RANBP2 OTFG5CVF Strong Biomarker [2]
------------------------------------------------------------------------------------

References

1 Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800035303)
2 A gene transfer comparative study of HSA-conjugated antiangiogenic factors in a transgenic mouse model of metastatic ocular cancer.Cancer Gene Ther. 2007 Mar;14(3):251-61. doi: 10.1038/sj.cgt.7701005. Epub 2006 Nov 3.